Published 1995
| Version v1
Journal article
Carbon-11 labeling of a potent, nonpeptide, AT1-selective angiotensin-II receptor antagonist: MK-996
- 1. Johns Hopkins Medical Institutions, Baltimore, MD (United States)
- 2. Merck Research Labs., West Point, PA (United States)
Description
[α-11C]Benzoyl chloride was synthesized and purified by normal phase HPLC. [11C]MK-996 ([11C]N-[[4'[(2-ethyl-5,7-dimethyl-3H-imidazo [4,5-b]pyridin-3-yl)methyl][1,1'-biphenyl]-2-yl]sulfonyl]-benzamide), a potent and selectrive ligand for the AT1 receptor, was prepared by N-benzoylation of L-159,221 with [α-11C]benzoyl chloride in tetrahydrofuran using lithium bis(trimethylsilyl)amide as a base. The radiotracer was purified by semi-preparative reverse-phase HPLC. The average specific activity was 1162 mCi/μmol calculated at end-of-synthesis (EOS). The average time of synthesis including formulation was 38 minutes. (Author)
Additional details
Publishing Information
- Journal Title
- Journal of Labelled Compounds and Radiopharmaceuticals
- Journal Volume
- 36
- Journal Issue
- 8
- Journal Page Range
- p. 729-737.
- ISSN
- 0362-4803
- CODEN
- JLCRD4
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- United Kingdom
- INIS RN
- 27046962
- Subject category
- S38: RADIATION CHEMISTRY, RADIOCHEMISTRY AND NUCLEAR CHEMISTRY;
- Descriptors DEI
- ANGIOTENSIN; CARBON 11; CHEMICAL PREPARATION; LABELLING; ORGANIC NITROGEN COMPOUNDS; RADIOPHARMACEUTICALS; RECEPTORS; TRACER TECHNIQUES
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; CARBON ISOTOPES; CARDIOVASCULAR AGENTS; DRUGS; EVEN-ODD NUCLEI; GLOBULINS; ISOTOPE APPLICATIONS; ISOTOPES; LABELLED COMPOUNDS; LIGHT NUCLEI; MATERIALS; MINUTES LIVING RADIOISOTOPES; NUCLEI; ORGANIC COMPOUNDS; PROTEINS; RADIOACTIVE MATERIALS; RADIOISOTOPES; SYNTHESIS; VASOCONSTRICTORS